Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus

Project: Research

Project Details

StatusFinished
Effective start/end date03/8/19 → 01/31/22

Funding

  • Janssen Research and Development LLC: $26,584.00